Sainz-Amo, R.; Rodero-Romero, A.; Monreal, E.; Chico-GarcÃa, J.L.; RodrÃguez-Jorge, F.; Fernández-Velasco, J.I.; Villarrubia, N.; Veiga-González, J.L.; de la Maza, S.S.; Masjuan, J.;
et al. Effect of Natalizumab on sNfL and sGFAP Levels in Multiple Sclerosis Patients. Int. J. Mol. Sci. 2024, 25, 13153.
https://doi.org/10.3390/ijms252313153
AMA Style
Sainz-Amo R, Rodero-Romero A, Monreal E, Chico-GarcÃa JL, RodrÃguez-Jorge F, Fernández-Velasco JI, Villarrubia N, Veiga-González JL, de la Maza SS, Masjuan J,
et al. Effect of Natalizumab on sNfL and sGFAP Levels in Multiple Sclerosis Patients. International Journal of Molecular Sciences. 2024; 25(23):13153.
https://doi.org/10.3390/ijms252313153
Chicago/Turabian Style
Sainz-Amo, Raquel, Alexander Rodero-Romero, Enric Monreal, Juan Luis Chico-GarcÃa, Fernando RodrÃguez-Jorge, Jose Ignacio Fernández-Velasco, Noelia Villarrubia, Jose Luis Veiga-González, Susana Sainz de la Maza, Jaime Masjuan,
and et al. 2024. "Effect of Natalizumab on sNfL and sGFAP Levels in Multiple Sclerosis Patients" International Journal of Molecular Sciences 25, no. 23: 13153.
https://doi.org/10.3390/ijms252313153
APA Style
Sainz-Amo, R., Rodero-Romero, A., Monreal, E., Chico-GarcÃa, J. L., RodrÃguez-Jorge, F., Fernández-Velasco, J. I., Villarrubia, N., Veiga-González, J. L., de la Maza, S. S., Masjuan, J., Costa-Frossard, L., & Villar, L. M.
(2024). Effect of Natalizumab on sNfL and sGFAP Levels in Multiple Sclerosis Patients. International Journal of Molecular Sciences, 25(23), 13153.
https://doi.org/10.3390/ijms252313153
